Layered double hydroxide-induced modulation of oxidative stress in disease therapy.
1/5 보강
Oxidative stress plays a crucial role in the development of various diseases, including diabetes, cardiovascular diseases, cancer, and rheumatic disorders.
APA
Wang J, Su O, et al. (2026). Layered double hydroxide-induced modulation of oxidative stress in disease therapy.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 195, 119063. https://doi.org/10.1016/j.biopha.2026.119063
MLA
Wang J, et al.. "Layered double hydroxide-induced modulation of oxidative stress in disease therapy.." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, vol. 195, 2026, pp. 119063.
PMID
41592521
Abstract
Oxidative stress plays a crucial role in the development of various diseases, including diabetes, cardiovascular diseases, cancer, and rheumatic disorders. It disrupts the redox balance and initiates a series of pathological changes. As two-dimensional inorganic solids with an open structure and anion-exchange properties, layered double hydroxides (LDHs) offer significant advantages in the biomedical field, such as drug carriers, antioxidant catalysts. This article outlines application of LDHs in the treatment of cancer, rheumatic diseases, bone disorders, diabetes, Alzheimer's disease, and other conditions. More importantly, this paper elaborates on the challenges faced by the application of LDHs, including the biological activity to be explored, the performance to be optimized, and their in vivo functions and molecular mechanisms to be clarified. The solution strategies have also been discussed, which pointed out the direction for promoting the clinical transformation and application of LDHs in the future.
MeSH Terms
Oxidative Stress; Humans; Hydroxides; Animals; Antioxidants; Drug Carriers; Neoplasms
같은 제1저자의 인용 많은 논문 (5)
- "A diamond-shaped" penoplasty technique with or without concurrent suprapubic liposuction for adult-acquired buried penis: clinical outcomes and patient satisfaction rates.
- A Systematic Review of Patient-Reported Outcomes for Cosmetic Indications of Botulinum Toxin Treatment.
- Impact of diagnosis-related group systems on inpatient expenditures and medical quality for children with leukemia: evidence from real-world data.
- A preliminary study to evaluate efficacy and safety of Lugol's solution following radioiodine for remnant ablation in differentiated thyroid cancer.
- Lentinan inhibits breast cancer cell growth through the dual downregulation of tumor-promoting effectors CD133 and SCGB2A2.